Gracell Biotechnologies • GRCL
Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Wei William Cao, PhD$989.9M
Market Cap • 22/02/20242018
(há 6 anos)
2021
(3 years ago)
NASDAQ
Listagem
Suzhou
314
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
GRCLSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.